SciSparc Ltd.
SciSparc is a specialty pharmaceutical company developing unique cannabinoid technologies for the treatment of central nervous system disorders. Their pipeline includes drug candidates in clinical trials for Tourette Syndrome, Obstructive Sleep Apnea, Alzheimer’s Disease, Agitation, and Autism Spectrum Disorder. The company focuses on improving the lives of those suffering from central nervous system disorders.
Official Registry
AI Quality Analysis
Trust Score Breakdown
Quick Links
Sivuston kohokohdat
🌟 Vastaavat luotettavat yritykset
Certara, Inc.
Certara provides comprehensive drug development solutions, integrating science, technology, and strategic expertise. They offer services from molecule to market, including regulatory navigation, model-informed drug development, and market access. Their software solutions align with industry standards, transforming drug development across all phases. Certara helps partners unlock their pipeline's potential and accelerate drug development milestones.
SERVIER OUTRE-MER
Servier is an independent international pharmaceutical company focused on therapeutic progress for patients. They invest significantly in research and development, particularly in oncology, cardiometabolism, and neuroscience. Servier is known for its long-term vision and commitment to patients' needs.
AGILERA PHARMA AS
Agilera on johtava CDMO, joka edistää teknologian kehitystä ja kasvua radiofarmaseuttisilla markkinoilla. He tarjoavat koko arvoketjun uusien radiofarmaseuttisten aineiden kehittämiseen, prekliinisestä vaiheesta kaupalliseen tuotantoon ja maailmanlaajuiseen jakeluun. Agileralla on valmistuslupa Yhdysvaltoihin, Japaniin, Eurooppaan, Latinalaiseen Amerikkaan ja Kiinaan.